SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-06-000056
Filing Date
2006-09-22
Accepted
2006-09-22 10:30:43
Documents
2
Period of Report
2006-09-22
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 DOR NDA FILED FOR ORBEC WITH FDA dororbecndafda.htm 8-K 20948
2 DOR PRESS RELEASE FOR ORBEC NDA FILED WITH FDA dorpressreleaseorbecndafda.htm EX-99.1 EXHIBIT 37353
  Complete submission text file 0000812796-06-000056.txt   59944
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 061103492
SIC: 2834 Pharmaceutical Preparations